文献速递技术与安全CT

低渗透压静脉碘对比剂CT检查中过敏及预处理临床影响

Clinical impact of allergy and pre-medication in CT studies with low-osmolality intravenous iodinated contrast media.
PubMed 文献 · Clin Radiol · 2021-12-29

回顾性分析2014年1月至2018年9月门诊CT中发生的碘对比剂过敏反应,36,920例中74例(0.2%)出现全身反应,轻、中、重度分别为54、17、4例,重度反应者均无既往碘对比剂过敏史,既往过敏者10例中9例为轻度,结论认为重度过敏反应罕见、缺乏显著危险因素且似乎不受预处理影响,需前瞻性研究重新评估预处理方案。

要点

  • 36,920例门诊CT中74例(0.2%)发生碘对比剂全身过敏反应,重度仅4例。
  • 重度反应患者均无既往碘对比剂过敏史;既往过敏者10例中9例为轻度、1例中度。
  • 轻、中、重度反应患者间患者特征无显著差异,重度反应缺乏显著危险因素。

核心结论

  • 碘对比剂重度过敏反应罕见、缺乏显著危险因素,且似乎不受预处理影响;作者认为需开展前瞻性研究重新评估预处理方案的收益。

研究设计与样本

  • 回顾性分析2014年1月至2018年9月门诊CT检查中发生碘对比剂过敏反应的患者资料,并按验证标准评估反应严重程度;对照组选自研究期间接受CT且未发生过敏反应者。

诊断标准与关键数值

  • 筛查36,920例CT检查,74例(0.2%)出现碘对比剂全身反应,其中轻度54例、中度17例、重度4例。
  • 既往碘对比剂过敏者10例(13.3%),其反应为轻度9/10、中度1/10,其中1例过敏反应强度较前次事件减轻。
  • 对照组中4例(4%)有既往碘对比剂过敏,这些个体未发生过敏反应不能归因于预处理。
  • 所有重度反应患者均无既往碘对比剂过敏史。

局限性

  • 作者指出需开展前瞻性研究重新评估预处理方案的收益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the occurrence and severity of allergic reactions to iodinated contrast media (ICM), including associated risk factors and the impact of pre-medication.

MATERIALS AND METHODS: Data on patients who had experienced allergic reactions during outpatient computed tomography (CT) examinations between January 2014 and September 2018 were analysed retrospectively. Response severity was assessed according to validated criteria. A control group was selected among individuals who underwent CT during the study period and did not experience allergic reactions.

RESULTS: Screening of 36,920 CT studies revealed 74 (0.2%) individuals with systemic reactions to ICM. No significant differences in patient characteristics were found among patients who experienced mild (n=54), moderate (n=17), or severe (n=4) reactions. Previous ICM allergy was reported in 10 patients (13.3%). Patients with a history of ICM allergy had mild (9/10) or moderate (1/10) reactions, with one individual showing decreased intensity of the allergic response compared to a previous event. Within the control group, four patients (4%) had previous ICM allergy. In these individuals, lack of allergic reactions could not be attributed to pre-medication. All patients with severe reactions did not have a prior history of ICM allergy.

CONCLUSION: Severe allergic reactions to ICM are rare, lack significant risk factors, and do not appear to be impacted by pre-medication. The findings presented herein highlight the need for prospective work that will re-evaluate the yield of pre-medication protocols.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Talmon, Tal, Moss, et al. Clinical impact of allergy and pre-medication in CT studies with low-osmolality intravenous iodinated contrast media. Clin Radiol. 2021. PMID: 34973806. doi:10.1016/j.crad.2021.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。